Home
About
Overview
Sharing Data
ORCID
Help
History (8)
PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety.
Update on PCSK9 therapies for the treatment of dyslipidemia.
Pealy, Elizabeth Starker
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial.
Co-Investigator
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Co-Investigator
Overview
researcher role of
Gibbons, Robert
contributes to
Emergency Department Screen for Teens at Risk for Suicide (ED-STARS)